Show results for
Refine by
Cancer Patient Suppliers Serving Norway
5 companies found
based inFremont, CALIFORNIA (USA)
BioGenex designs, develops and commercializes molecular pathology systems for Tumor diagnosis, prognosis, precision medicine and life science research. BioGenex’s industry-leading next-generation cytogenetic FISH workflow solution and miRNA system ...
based inBoston, MASSACHUSETTS (USA)
SOPHiA GENETICS is the creator of a global data-sharing network – we work with customers from over 790 institutions in over 70 countries. Our network advances data-driven medicine to improve health outcomes and economics worldwide. We offer a ...
The goal of the French Kidney Cancer Research Network (Réseau Français de Recherche sur le Cancer du Rein) is to connect a National, multidisciplinary network of medical and scientific professionals who focus on therapeutic ...
based inSeo-gu, SOUTH KOREA
Through more than 40 years of steady technological and market development, TPC Mechatronics Corp. has secured its position as the largest Korean manufacturer of pneumatic equipment, a key part of factory automation. Adding the motion control, 3D ...
The World's First and the Only 3D bioprinter in Korea capable of printing both low and high-viscosity ...
based inPetah Tikva, ISRAEL
Isotopia Molecular Imaging was established in 2007 by renowned Israeli scientists and experts in the field of radio pharmaceuticals, and in collaboration with the International Metronotario investment organization. Advancing cancer diagnosis and ...
Lutetium-177 (Lu-177) is being widely used as a promising radionuclide for targeted therapy and is emerging as a game-changing theranostic isotope for the treatment of neuroendocrine tumors, metastatic castration-resistant prostate cancer (mCRPC) ...
based inGolestan Town, IRAN
Pishtaz Teb Zaman Diagnostics, started its research, development, and marketing activities in 1998, and rapidly grew to be an international brand specialized in 'In-Vitro Diagnostics Medical Devices and Clinical research'. Our range of products are ...
Carcinoembroyonic antigen (CEA) is a 150300 kD glycoprotein molecule which has been found by Gold and Freedman at 1965 and it is also known as major component of CEA glycoprotein family. This family consists of 36 different glycoproteins with the ...